Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AY57
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.498 |
CLV_PCSK_FUR_1 | 16 | 20 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.498 |
CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.585 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.613 |
DEG_SPOP_SBC_1 | 53 | 57 | PF00917 | 0.450 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.369 |
LIG_14-3-3_CanoR_1 | 18 | 27 | PF00244 | 0.594 |
LIG_Clathr_ClatBox_1 | 97 | 101 | PF01394 | 0.436 |
LIG_deltaCOP1_diTrp_1 | 43 | 49 | PF00928 | 0.325 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.434 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.581 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.427 |
LIG_LIR_Gen_1 | 22 | 30 | PF02991 | 0.524 |
LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.267 |
LIG_LIR_LC3C_4 | 122 | 127 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 22 | 27 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 74 | 79 | PF02991 | 0.474 |
LIG_PCNA_PIPBox_1 | 58 | 67 | PF02747 | 0.494 |
LIG_PCNA_yPIPBox_3 | 58 | 69 | PF02747 | 0.494 |
LIG_Pex14_1 | 45 | 49 | PF04695 | 0.361 |
LIG_SH2_NCK_1 | 95 | 99 | PF00017 | 0.428 |
LIG_SH2_STAP1 | 106 | 110 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.329 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.489 |
LIG_SUMO_SIM_par_1 | 96 | 102 | PF11976 | 0.412 |
LIG_TRAF2_1 | 56 | 59 | PF00917 | 0.494 |
LIG_WRC_WIRS_1 | 65 | 70 | PF05994 | 0.494 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.527 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.492 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.498 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.508 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.472 |
MOD_N-GLC_1 | 113 | 118 | PF02516 | 0.196 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.581 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.497 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.433 |
MOD_NEK2_2 | 64 | 69 | PF00069 | 0.492 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.608 |
MOD_PIKK_1 | 54 | 60 | PF00454 | 0.497 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.501 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.451 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.385 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.573 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.428 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.521 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.492 |
TRG_Pf-PMV_PEXEL_1 | 108 | 112 | PF00026 | 0.262 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVV4 | Leptomonas seymouri | 75% | 100% |
A0A0S4J314 | Bodo saltans | 32% | 100% |
A0A3R7NI30 | Trypanosoma rangeli | 45% | 95% |
A0A3S7WZQ8 | Leishmania donovani | 96% | 100% |
A4HET3 | Leishmania braziliensis | 89% | 100% |
A4I209 | Leishmania infantum | 96% | 100% |
C9ZS03 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 97% |
Q21832 | Caenorhabditis elegans | 33% | 100% |
Q4Q9B6 | Leishmania major | 95% | 100% |